Group 4F: Inflammatory Breast Cancer; ER+ Breast & Endometrial Cancer—Metastatic

Friday, June 10
10:00 am – 11:30 am Eastern Time (US/New York)

Mentor: Ginny Mason, R.N.

Ginny Mason is a nurse who was diagnosed with stage 3C inflammatory breast cancer 25 years ago. Her diagnosis of a less common and very aggressive breast cancer led her down an over 20- year career path in patient advocacy. She has been with Inflammatory Breast Cancer Research Foundation since its inception in 1999 and currently serves as the executive director.

Ginny works in a variety of capacities as a board member, advisor, mentor, grant reviewer and medical consultant for a variety of organizations, including ASCO, the Department of Defense, the American Association of Cancer Research, the U.S. Food and Drug Administration, Komen Advocates in Science, and various other advisory/consultant roles with other organizations.

Ginny is a graduate of the Project Lead Institute and serves as a member of the breast committee of the Southwest Oncology Group (SWOG), the Indiana University representative for the Translational Breast Cancer Research Consortium (TBCRC), and the Brain Metastasis and Research Working Group of the Metastatic Breast Cancer Alliance.

Twitter: @IBCnurse, @IBCResearch

Scientist: Stephanie Graff, M.D.

Stephanie L. Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute, and co-leader of the Breast Cancer Translational Research Disease Group. In addition, she serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research. She is active across numerous professional organizations in oncology, including the American Society of Clinical Oncology (ASCO) where she is a 2020 graduate of the prestigious Leadership Development Program and currently serves on the Joint Certifications Committee; the Rhode Island Leadership Council for the American Cancer Society; the Breast Cancer Committee for the Alliance for Clinical Trials in Oncology cooperative group; and is on the Health Disparities Council for the Caris Precision Oncology Alliance (POA) and is chair-elect for the Breast Disease group of the Caris POA. Dr. Graff is a leader on social media and a sought-after public speaker.

Research Interests include oncology drug development and clinical trials, the breast microbiome, breast cancer genomics, health disparities, women in medicine, and rare breast cancers including male breast cancer, pregnancy-associated breast cancer, pre-menopausal breast cancer, among others.

Twitter: @DrSGraff